|
TWI389893B
(zh)
|
2007-07-06 |
2013-03-21 |
Astellas Pharma Inc |
二（芳胺基）芳基化合物
|
|
EP2215091B1
(en)
*
|
2007-12-04 |
2016-03-30 |
Nerviano Medical Sciences S.r.l. |
Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
|
|
CA2723961C
(en)
|
2008-05-21 |
2017-03-21 |
Ariad Pharmaceuticals, Inc. |
Phosphorous derivatives as kinase inhibitors
|
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
|
PL2428508T3
(pl)
|
2009-05-08 |
2016-05-31 |
Astellas Pharma Inc |
Diaminoheterocykliczny związek karboksyamidowy
|
|
TW201100441A
(en)
|
2009-06-01 |
2011-01-01 |
Osi Pharm Inc |
Amino pyrimidine anticancer compounds
|
|
WO2011032050A2
(en)
*
|
2009-09-11 |
2011-03-17 |
Trius Therapeutics, Inc. |
Gyrase inhibitors
|
|
JP2013522215A
(ja)
|
2010-03-09 |
2013-06-13 |
オーエスアイ・ファーマシューティカルズ，エルエルシー |
組合わせ抗癌療法
|
|
GB201007286D0
(en)
|
2010-04-30 |
2010-06-16 |
Astex Therapeutics Ltd |
New compounds
|
|
PT2646448T
(pt)
|
2010-11-29 |
2017-10-04 |
Osi Pharmaceuticals Llc |
Inibidores macrocíclicos de cinases
|
|
GB201106817D0
(en)
*
|
2011-04-21 |
2011-06-01 |
Astex Therapeutics Ltd |
New compound
|
|
CN103501612B
(zh)
|
2011-05-04 |
2017-03-29 |
阿里亚德医药股份有限公司 |
抑制表皮生长因子受体导致的癌症中细胞增殖的化合物
|
|
FR2980477B1
(fr)
*
|
2011-09-23 |
2013-10-18 |
Centre Nat Rech Scient |
Nouveaux composes modulateurs de la voie de signalisation des proteines hedgehog, leurs formes marquees, et applications
|
|
FR2984318B1
(fr)
|
2011-12-16 |
2014-06-27 |
Oreal |
Coupleur de structure 7 amino-1,2,3,4-tetrahydroquinoleines cationiques, composition tinctoriale en comprenant, procedes et utilisations
|
|
FR2984323B1
(fr)
*
|
2011-12-16 |
2019-08-30 |
L'oreal |
Coupleur de structure 7 amino-1,2,3,4-tetrahydroquinoleines, composition tinctoriale en comprenant, procedes et utilisations
|
|
US9034885B2
(en)
|
2012-01-13 |
2015-05-19 |
Acea Biosciences Inc. |
EGFR modulators and uses thereof
|
|
US9586965B2
(en)
|
2012-01-13 |
2017-03-07 |
Acea Biosciences Inc. |
Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases
|
|
US9464089B2
(en)
|
2012-01-13 |
2016-10-11 |
Acea Biosciences Inc. |
Heterocyclic compounds and uses thereof
|
|
CA2861010A1
(en)
|
2012-01-13 |
2013-07-18 |
Xiao Xu |
Heterocyclic compounds and uses as anticancer agents
|
|
WO2013169401A1
(en)
|
2012-05-05 |
2013-11-14 |
Ariad Pharmaceuticals, Inc. |
Compounds for inhibiting cell proliferation in egfr-driven cancers
|
|
UY34807A
(es)
|
2012-05-16 |
2013-12-31 |
Novartis Ag |
Derivados monocíclicos de heteroarilcicloalquil- diamina
|
|
GB201209613D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
|
CN103655572A
(zh)
*
|
2012-09-17 |
2014-03-26 |
杨育新 |
一类治疗创伤性脑损伤疾病的化合物及其用途
|
|
CN103804382A
(zh)
*
|
2012-11-05 |
2014-05-21 |
韩文毅 |
一类治疗湿疹的化合物及其用途
|
|
CN104854101B
(zh)
*
|
2012-11-06 |
2018-05-01 |
上海复尚慧创医药研究有限公司 |
Alk激酶抑制剂
|
|
US9611283B1
(en)
|
2013-04-10 |
2017-04-04 |
Ariad Pharmaceuticals, Inc. |
Methods for inhibiting cell proliferation in ALK-driven cancers
|
|
CN117486865A
(zh)
|
2013-07-11 |
2024-02-02 |
艾森医药公司 |
嘧啶衍生物作为激酶抑制剂
|
|
MY186311A
(en)
|
2013-12-20 |
2021-07-08 |
Astex Therapeutics Ltd |
Bicyclic heterocycle compounds and their uses in therapy
|
|
US9957270B2
(en)
|
2014-03-13 |
2018-05-01 |
Agency For Science, Technology And Research |
Fused pyrimidine-based hydroxamate derivatives
|
|
HUE053654T2
(hu)
|
2014-03-26 |
2021-07-28 |
Astex Therapeutics Ltd |
FGFR- és CMET-inhibitorok kombinációi a rák kezelésére
|
|
JO3512B1
(ar)
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
|
|
RU2715893C2
(ru)
|
2014-03-26 |
2020-03-04 |
Астекс Терапьютикс Лтд |
Комбинации ингибитора fgfr и ингибитора igf1r
|
|
JOP20200201A1
(ar)
|
2015-02-10 |
2017-06-16 |
Astex Therapeutics Ltd |
تركيبات صيدلانية تشتمل على n-(3.5- ثنائي ميثوكسي فينيل)-n'-(1-ميثيل إيثيل)-n-[3-(ميثيل-1h-بيرازول-4-يل) كينوكسالين-6-يل]إيثان-1.2-ثنائي الأمين
|
|
EP3778604A1
(en)
*
|
2015-02-13 |
2021-02-17 |
Dana Farber Cancer Institute, Inc. |
Lrrk2 inhibitors and methods of making and using the same
|
|
US10478494B2
(en)
|
2015-04-03 |
2019-11-19 |
Astex Therapeutics Ltd |
FGFR/PD-1 combination therapy for the treatment of cancer
|
|
CN111440189B
(zh)
*
|
2015-04-24 |
2022-08-09 |
广州再极医药科技有限公司 |
稠环嘧啶氨基衍生物、其制备方法、中间体、药物组合物及应用
|
|
SI3353177T1
(sl)
|
2015-09-23 |
2020-08-31 |
Janssen Pharmaceutica Nv |
Triciklični heterocikli za zdravljenje raka
|
|
EP3353164B1
(en)
|
2015-09-23 |
2021-11-03 |
Janssen Pharmaceutica, N.V. |
Bi-heteroaryl substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
|
|
MX2018004332A
(es)
|
2015-10-09 |
2019-01-10 |
Acea Therapeutics Inc |
Sales farmaceuticas, formas fisicas y composiciones de inhibidores de pirrolopirimidina cinasa, y metodos para fabricar las mismas.
|
|
CN107793417B
(zh)
*
|
2016-09-05 |
2020-06-09 |
复旦大学 |
吡咯并[2,3-d]嘧啶类化合物及其盐，及制备方法和药用用途
|
|
CN106432054A
(zh)
*
|
2016-09-17 |
2017-02-22 |
青岛云天生物技术有限公司 |
制备4‑（哌啶‑3‑基）苯胺的方法
|
|
EP3528816A4
(en)
*
|
2016-10-21 |
2020-04-08 |
Nimbus Lakshmi, Inc. |
TYK2 INHIBITORS AND USES THEREOF
|
|
CN110114357B
(zh)
*
|
2016-10-28 |
2022-05-31 |
百时美施贵宝公司 |
可用作IL-12、IL-23和/或IFNα反应的调节剂的杂双环化合物
|
|
BR112019020840A2
(pt)
|
2017-04-07 |
2020-04-28 |
Acea Therapeutics Inc |
sais farmacêuticos, formas físicas e composições de inibidores da pirrolopirimidina quinase e métodos de produção dos mesmos
|
|
WO2019081486A1
(en)
|
2017-10-24 |
2019-05-02 |
Bayer Aktiengesellschaft |
4H-PYRROLO [3,2-C] PYRIDIN-4-ONE DERIVATIVES
|
|
EP3731845A4
(en)
*
|
2017-12-28 |
2021-10-06 |
Development Center for Biotechnology |
HETEROCYCLIC COMPOUNDS AS TYRO3, AXL AND MERTK (TAM) FAMILY OF RECEPTOR TYROSINKINASE INHIBITORS
|
|
KR102548191B1
(ko)
*
|
2018-04-09 |
2023-06-28 |
상하이테크 유니버시티 |
표적 단백질 분해 화합물, 이의 항종양 응용, 이의 중간체 및 중간체의 응용
|
|
EP3959212A1
(en)
|
2019-04-24 |
2022-03-02 |
Bayer Aktiengesellschaft |
4h-pyrrolo[3,2-c]pyridin-4-one compounds
|
|
MX2021012987A
(es)
|
2019-04-24 |
2022-04-01 |
Bayer Ag |
Compuestos de 4h-pirrolo[3,2-c]piridin-4-ona.
|
|
US20220378762A1
(en)
|
2019-04-24 |
2022-12-01 |
Bayer Aktiengesellschaft |
4h-pyrrolo[3,2-c]pyridin-4-one derivatives
|
|
CN110294721A
(zh)
*
|
2019-07-22 |
2019-10-01 |
安庆缘启医药科技有限公司 |
1-乙酰基-4-[3-(甲基氧基)-4-硝基苯基]哌嗪的合成工艺
|
|
WO2021152113A1
(en)
|
2020-01-31 |
2021-08-05 |
Bayer Aktiengesellschaft |
Substituted 2,3-benzodiazepines derivatives
|
|
WO2021198020A1
(en)
|
2020-03-31 |
2021-10-07 |
Bayer Aktiengesellschaft |
3-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancer
|
|
CN114230524A
(zh)
*
|
2021-12-28 |
2022-03-25 |
南通大学 |
(5-氟-2-苯胺嘧啶-4-基)氨基-n-羟基苯甲酰胺衍生物及其制备方法与应用
|
|
CN114031559A
(zh)
*
|
2021-12-28 |
2022-02-11 |
南通大学 |
基于芳基含氮杂环修饰的5-氟-嘧啶二胺苯甲酸酯及其制备方法与应用
|
|
CN114349670A
(zh)
*
|
2022-02-17 |
2022-04-15 |
吉林大学 |
一种含侧链砜基结构的二胺单体、聚酰亚胺及其制备方法和应用
|
|
CN115089589A
(zh)
*
|
2022-06-10 |
2022-09-23 |
杭州市肿瘤医院 |
激酶抑制剂gsk1838705a在制备抑制食管癌的药物中的应用
|